ACCENDRA HEALTH INC/VA/ 8-K

What Happened
Accendra Health, Inc. announced its financial results for the fourth quarter and the fiscal year ended December 31, 2025, in a press release issued on February 19, 2026. The company also posted an earnings presentation to the Investor Relations section of its website the same day. These disclosures were furnished to the SEC as Exhibit 99.1 (press release) and Exhibit 99.2 (presentation) under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Key Details

• Date of filing and disclosures: February 19, 2026.
• Reporting period: Fourth quarter and year ended December 31, 2025.
• Exhibits furnished to the SEC: Exhibit 99.1 — press release; Exhibit 99.2 — earnings presentation (posted on company website).
• Items reported in the Form 8-K: Item 2.02 (results of operations) and Item 7.01 (Regulation FD disclosure).

Why It Matters
This 8-K is the company’s formal way of making its Q4 and full-year 2025 financial results and supporting presentation publicly available. Retail investors should review the press release and the posted presentation for the actual financial metrics (revenue, profit/loss, cash position, and management commentary) and any guidance or key operational highlights. Because the information was posted under Regulation FD and furnished to the SEC, it is broadly available to all investors at the same time. For investment decisions, read the attached exhibits and the company’s subsequent reports for full financial statements and discussion.